Compartilhar

Estudo experimental da eficácia clínica e microbiológica da associação do diclofenaco sódico e sulfato de gentamicina no tratamento da ceratite por Pseudomonas aeruginosa

Estudo experimental da eficácia clínica e microbiológica da associação do diclofenaco sódico e sulfato de gentamicina no tratamento da ceratite por Pseudomonas aeruginosa

Autores:

Belquiz A. Nassaralla,
Procópio M. dos Santos,
Xun W. Wang,
Won R. Wee,
Manoel Pinheiro Jr.,
João J. Nassaralla Jr.,
T. Al Reaves,
Arthur Jauch,
Peter McDonnell

ARTIGO ORIGINAL

Arquivos Brasileiros de Oftalmologia

versão impressa ISSN 0004-2749versão On-line ISSN 1678-2925

Arq. Bras. Oftalmol. vol.60 no.5 São Paulo out. 1997

http://dx.doi.org/10.5935/0004-2749.19970034

SUMMARY

Purpose:

Comparing the effect of the combination of sodium diclofenac-gentamicin sulfate to 0.3% gentamicin alone and diclofenac alone in an animal model of Pseudomonas keratitis.

Methods:

Sixty rabbits were randomized into six masked groups of 10 rabbits. Animals were randomly assigned to one of the six coded treatment groups as follow: Group I (0.1% sodium diclofenac - 0.3% gentamicin sulfate; Group II (vehicle of 0.1% sodium diclofenac 0.1% - 0.3% gentamicin sulfate); Group III (0.1% sodium diclofenac); Group IV (0.3% gentamicin sulfate); Group V (BSS); Group VI (was sacrificed to establish the baseline of bacterial corneal growth). Drugs were administered hourly in the first day, and seven times a day for the next six days. Conjunctival swabs and clinical evaluations were performed before infection and on days 1, 3 and 8. Rabbits were sacrificed 8 days after infection, and the number of bacteria was quantified.

Results:

The number of rabbits with descemetocele at day 3 was hightest in groups V and III, with statistically significant difference between them. None of the animals in the gentamicin group needed to be sacrificed. By days 3 and 8, conjunctival and corneal clinical signs in all groups were similar. Groups I and IV had the lowest scores and groups II and III had the highest scores, but there was no significant difference among them. There was no significant difference between the number of colonies of Pseudomonas counted from specimens of conjunctiva and cornea during the experiment.

Conclusion:

0.1% sodium diclofenac therapy does not adversely affect the results of antibiotic therapy with 0.3% gentamicin sulfate in the treatment of experimental Pseudomonas keratitis.

REFERÊNCIAS

1 ABBOTT, R. L & ABRAMS, M. A. - Bacterial corneal ulcers. In: TASMAN, W & JAEGER, E. A. Duane's clinical ophthalmology. Philadelphia, J. B. Lippincott, 1992. p. 1-34.
2 ASSIL, K. K.; FRUCHT-PERRY, J.; ZIEGLER, E.; SCHANZLIN, D. J.; SCHNEIDERMAN, T.; WEINREB, R. N. - Tobramycin liposomes: single subconjunctival therapy of Pseudomonas keratitis. Invest. Ophthalmol. Vis. Sci., 32: 3216-20, 1991.
3 ASSIL, K. K.; ZARNEGAR, S. R.; FOURAKER, B. D.; SCHANZLIN, D. J. - Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental. Pseudomonas aeruginosa - induced keratitis in rabbits. Am. J. Ophthalmol., 113: 418-23, 1992.
4 BOHIGIAN, G. M. & FOSTER, C. S. - Treatment of Pseudomonas keratitis in the rabbit with antibiotic-steroid combinations. Invest. Ophthalmol. Vis. Sci., 16: 553-6, 1977.
5 DAVIS, S. D. & CHAMDLER, J. W. - Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs. Antimicrob. Agents Chemother., 8: 350-5, 1975
6 GRITZ, D. C.; KWITKO, S.; TROUSDALE, M. D.; GONZALEZ, V. H.; McDONNELL, P. J. - Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model. Cornea, 11: 404-8, 1992.
7 HYNDIUK, R. A. - Experimental Pseudomonas keratitis. Trans. Am. Ophthalmol. Soc., 79: 541- 624, 1981.
8 HYNDIUK, R. A.; DAVIS, S. D.; HATCHELL, D. L.; BURD, E. M. - Experimental Pseudomonas keratitis: clinical and pathological observations. Cornea, 2: 103-14, 1983.
9 HYNDIUK, R. A.; SKORICH, D. N., DAVIS, S. D., SARFF, L. D.; DIVINE, K.; BURD, E. - Fortified antibiotic ointment in bacterial keratitis. Am. J. Ophthalmol., 105: 239- 43, 1988.
10 KANTOR, T. G. - Current modalities in arthitic diseases. Am. J. Med., 83(suppl. 4B): 2-5, 1987.
11 LAIBSON, P.; MICHAUD, R.; SMOLIN, G.; OKUMOTO, M.; ROSENTHAL, A.; CAGLE, G. - A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections. Am. J. Ophthalmol., 92: 836-41, 1981.
12 LIMA, A. L. H.; GUIDUGLI, T.; ALMADA, A. T.; BELFORT Jr, R., FERRARI, J. A. - Avaliação in vitro da atividade da tobramicina em infecções oculares. Rev. Bras. Oftalmol., 44 (suppl. 4): 141-5, 1985.
13 MCDONALD, T. O. & SHADDUCK, J. A. - Eye irritation. In: MARZULLI, F. N. & MAIBACH, H. I. ed - Advances modern toxicology. New York, Wiley, 1977. p. 139.
14 NASSARALLA, B. A.; SZERENYI, K.; WANG, X. W.; REAVES, T. A.; McDONNELL, P. J. - Effect of diclofenac on corneal haze after pho-torefractive keratectomy in rabbits. Ophthalmology, 102: 469-74, 1995.
15 POLACK, F. M. - Ceratite bacteriana. In: Enfermidades oculares externas. Barcelona, Ediciones Scriba, 1992. p. 130.
16 PRIMBS, G. B.; SAND, B. J.; STRAATSMA, B. R. - Observations on experimental corneal ulcers. Arch. Ophthalmol., 66: 564-9, 1961.
17 SANTOS, P.'M.; NISHI, M.; GÜNTZEL.; LIMA, A. L. H. - Princípios básicos do diagnóstico das infecções oculares. In: LIMA, A. L. H.; MELAMED, J.; CALIXTO, N. ed - Terapêutica clínica ocular. São Paulo, Roca, 1995. p. 331-51